F2 Vision SCS - Insider Trading & Ownership

Entity
Individual
Location
74 Grand Rue, Luxemburg, Luxembourg
Summary
The estimated net worth of F2 Vision SCS is at least $55.8M dollars as of August 4, 2022. F2 Vision SCS is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $55.8M.
All Insider Reports
All Insider Reports

Ownership of F2 Vision SCS

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $55.8M Aug 2, 2022

Insider Transactions Reported by F2 Vision SCS:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.